The pregnant women exposed to nevirapine with CD4 > = 250 cells/mm3 did not present a higher occurrence of hepatic alteration (p = 1.00) or ART medication-related allergic reaction (p = 1.00) (data not shown). The gene discussed is CD4; the disease is allergic disease.